CareDx to Participate in the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference

Audio By Carbonatix

BRISBANE, Calif.--(BUSINESS WIRE)--Jan 27, 2026--

CareDx, Inc. (Nasdaq: CDNA) - The Transplant Company™ —, a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high‑value healthcare solutions for transplant patients and caregivers, today announced the company will participate in the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference in Snowbird, UT on Tuesday, February 10, 2026.

About CareDx

CareDx is a precision medicine company dedicated to improving outcomes for transplant patients and advancing organ health. The Company’s integrated solutions include non‑invasive molecular testing for heart, kidney, and lung transplants; laboratory products; digital health technologies; and patient solutions that support care before and after transplant. CareDx is the leading provider of genomics‑based information for transplant patients. For more information, please visit www.caredx.com.

View source version on businesswire.com:https://www.businesswire.com/news/home/20260127761296/en/

CONTACT: Investor Relations

Caroline Corner

[email protected]

KEYWORD: CALIFORNIA UTAH UNITED STATES NORTH AMERICA

INDUSTRY KEYWORD: HEALTH SURGERY HEALTH TECHNOLOGY OTHER HEALTH MANAGED CARE CARDIOLOGY

SOURCE: CareDx, Inc.

Copyright Business Wire 2026.

PUB: 01/27/2026 04:05 PM/DISC: 01/27/2026 04:05 PM

http://www.businesswire.com/news/home/20260127761296/en